Progress on RNAi-based molecular medicines
Jing Chen, Jianping XieInstitute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Ministry of Education Eco-Environment of the Three Gorges Reservoir Region, School of Life Sciences, Southwest University, Chongqing, ChinaAbstract: RNA interference (RNAi) is a promising strategy to...
Guardado en:
Autores principales: | Chen J, Xie JP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/efa2847a5351490ab47f15dfe5f76028 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system
por: Wang S, et al.
Publicado: (2018) -
A novel strategy for the discrimination of gelatinous Chinese medicines based on enzymatic digestion followed by nano-flow liquid chromatography in tandem with orbitrap mass spectrum detection
por: Yang H, et al.
Publicado: (2015) -
Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
por: Grafals-Ruiz N, et al.
Publicado: (2020) -
Nanotechnology-based drug delivery systems and herbal medicines: a review
por: Bonifácio BV, et al.
Publicado: (2013) -
Photoactivatable RNAi for cancer gene therapy triggered by near-infrared-irradiated single-walled carbon nanotubes
por: Ren XL, et al.
Publicado: (2017)